BrightSpring Q1 revenue up 27%, net loss $46M; raises FY 2024 guidance

BrightSpring Health Services, Inc.

2024-Q1 EPS reported -$0.26 revenue$2,576,638,000

Net revenue of $2.577B, up 27% YoY; adjusted EBITDA $131M, up 13.2%.
Pharmacy Solutions revenue $1.977B (+35%); Provider Services revenue $600M (+7%).
Net loss of $46M, widened from $22M loss in Q1 2023.
Raised FY 2024 guidance: revenue $10.3-10.8B, Adj. EBITDA $555-570M (excl. QIP).
Appointed Olivia Kirtley and Timothy Wicks (ex-Optum EVP) to Board of Directors.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

BrightSpring Health Services, Inc. reported first quarter ended March 31, 2024 results: revenue $2,577 million, net income Net loss of $46 million. Guidance raised.

Period: first quarter ended March 31, 2024
Revenue: $2,577 million
Net income: Net loss of $46 million
Guidance: raised
Result: reported results

Exact text from the filing

today announced financial results for the first quarter ended March 31, 2024, and increases 2024 revenue and Adjusted EBITDA 1 guidance. Financial Highlights • Net Revenue of $2,577 million, up 27.0% compared to $2,028 million in the first quarter of 2023. • Net loss of $46 million, compared to net loss of $22 million in the first quarter of 2023. • Adjusted EBITDA

View on SEC.gov

222 earnings releases filed in the last 30 days. Browse all earnings releases →

BrightSpring Health Services, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-051549

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.